Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00048061 · ClinicalTrials.gov registry record · Phase 3
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
A Phase 3 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,609
- Enrollment target
NCT00048061 is a Phase 3 study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 1,609 participants.
The verdict
NCT00048061, a Phase 3 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,609 participants
- Enrollment target
Study Summary
This study will compare the efficacy and safety of different treatment regimens of oral Bonviva tablets in women with post-menopausal osteoporosis. Patients will also receive daily supplementation with vitamin D and calcium. The anticipated time of study treatment is 2+ years, and the target sample size is 500+ individuals.
Interventions
- DIETARY_SUPPLEMENT Calcium
- DRUG Ibandronate [Bonviva/Boniva]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,609 participants |
| Start Date | 2002-04 |
| Est. Completion | 2004-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00048061
The ClinicalTrials.gov registry entry for NCT00048061 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,609 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Calcium is the first listed.
NCT00048061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00048061 about?
NCT00048061 is a clinical study titled "MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis". This study will compare the efficacy and safety of different treatment regimens of oral Bonviva tablets in women with post-menopausal osteoporosis. Patients will also receive daily supplementation with vitamin D and calcium. The anticipated time of study treatment is 2+ years, and the target sample ...
What is the current status of trial NCT00048061?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,609 participants. The study started on 2002-04. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00048061?
The interventions under investigation include: Calcium (DIETARY_SUPPLEMENT), Ibandronate [Bonviva/Boniva] (DRUG).
Who is sponsoring clinical trial NCT00048061?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.